{
	"symbol": "MSCL",
	"name": "Satellos Bioscience Inc.",
	"price": 0.61,
	"priceChange": -0.02,
	"percentChange": -3.174603,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 25560,
	"openPrice": 0.64,
	"dayHigh": 0.64,
	"dayLow": 0.61,
	"MarketCap": 107546269,
	"MarketCapAllClasses": 101190132,
	"peRatio": "",
	"prevClose": 0.63,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 0.684581,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.",
	"fulldescription": "Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.",
	"website": "https://www.satellos.com",
	"email": "",
	"phoneNumber": "+1 905 336-6128",
	"fullAddress": "65 Front Street East,Suite 201, Toronto, ON, CA",
	"employees": "14",
	"shareOutStanding": 176305359,
	"totalDebtToEquity": 0,
	"totalSharesOutStanding": 165885462,
	"sharesESCROW": null,
	"vwap": 0.624897959,
	"dividendPayDate": null,
	"weeks52high": 1.32,
	"weeks52low": 0.45,
	"alpha": 0.002055,
	"averageVolume10D": 115546,
	"averageVolume20D": 150409,
	"averageVolume30D": 194129,
	"averageVolume50D": 164870,
	"priceToBook": 2.43,
	"priceToCashFlow": -3.4,
	"returnOnEquity": -71.76,
	"returnOnAssets": -66.16,
	"day21MovingAvg": 0.582857,
	"day50MovingAvg": 0.6248,
	"day200MovingAvg": 0.7301,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 0.61,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}